drugset / Trial / NCT03937869
Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
NaSingle-groupOpen-labelTreatment
Summary
A multi-center, open-label study to evaluate the treatment of one oral dose of 2g Solosec™ (Secnidazole) in adolescent girls with BV
Timeline
- Start
- 2018-11-28
- Primary completion
- 2020-11-05
- Completion
- 2020-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secnidazole | Small molecule | 2 g | Oral |